Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of bioactive molecules with potential antidepressant, anxiolytic, or antipsychotic properties. The presence of the trifluoromethyl group enhances metabolic stability and influences binding affinity to neurological receptors. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates targeting neurotransmitter systems. Also utilized in the preparation of chiral building blocks for asymmetric synthesis in drug discovery programs.